Search results
Results from the WOW.Com Content Network
The World Health Organization said officials have prequalified a new vaccine for dengue, a virus spread by mosquitoes largely in countries with tropical climates.. The U.S. Centers for Disease ...
Takeda's vaccine, given in two doses over a three-month interval, protects against four serotypes of the dengue virus. It was cleared by WHO for use in children aged 6 to 16 in areas with high ...
Dengue can be caused by dengue virus strains 1, 2, 3 or 4, with a person being infected multiple times over the course of their life, Duszynski told ABC News, so a vaccine may be able to help ...
The two-dose vaccine protects against the four types of dengue. Takeda’s dengue vaccine, known as Qdenga, was previously given the nod by the European Medicines Agency in 2022. WHO’s approval now means that donors and other U.N. agencies can purchase the vaccine for poorer countries. Studies have shown Takeda’s vaccine is about 84% ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
Dengue is spread by several species of female mosquitoes of the Aedes genus, principally Aedes aegypti. [1] Infection can be prevented by mosquito elimination and the prevention of bites. [12] Two types of dengue vaccine have been approved and are commercially available.
The Advisory Committee on Immunization Practices recommends the dengue vaccine, Dengvaxia, for children 9–16 years old with prior laboratory-confirmed dengue virus infection and living in areas ...
The rapid spread of dengue has caused 40 confirmed deaths, the ministry said, and a further 265 are being investigated. ... Brazil has bought 5.2 million doses of the dengue vaccine Qdenga ...